Connection
David Schwartz to Dose-Response Relationship, Drug
This is a "connection" page, showing publications David Schwartz has written about Dose-Response Relationship, Drug.
|
|
Connection Strength |
|
|
|
|
|
0.279 |
|
|
|
-
Kurche JS, Dobrinskikh E, Hennessy CE, Huber J, Estrella A, Hancock LA, Schwarz MI, Okamoto T, Cool CD, Yang IV, Evans CM, Schwartz DA. Muc5b Enhances Murine Honeycomb-like Cyst Formation. Am J Respir Cell Mol Biol. 2019 10; 61(4):544-546.
Score: 0.128
-
Sundy JS, Wood WA, Watt JL, Kline JN, Schwartz DA. Safety of incremental inhaled lipopolysaccharide challenge in humans. J Endotoxin Res. 2006; 12(2):113-9.
Score: 0.050
-
Schwartz DA. The role of TLR4 in endotoxin responsiveness in humans. J Endotoxin Res. 2001; 7(5):389-93.
Score: 0.035
-
Kline JN, Cowden JD, Hunninghake GW, Schutte BC, Watt JL, Wohlford-Lenane CL, Powers LS, Jones MP, Schwartz DA. Variable airway responsiveness to inhaled lipopolysaccharide. Am J Respir Crit Care Med. 1999 Jul; 160(1):297-303.
Score: 0.032
-
Schmidt LE, Thorne PS, Watt JL, Schwartz DA. Is an abbreviated bronchial challenge with histamine valid? Chest. 1992 Jan; 101(1):141-5.
Score: 0.019
-
Huang YC, Li Z, Carter JD, Soukup JM, Schwartz DA, Yang IV. Fine ambient particles induce oxidative stress and metal binding genes in human alveolar macrophages. Am J Respir Cell Mol Biol. 2009 Nov; 41(5):544-52.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|